GenMark Diagnostics Current Ratio 2010-2020 | GNMK

GenMark Diagnostics current ratio from 2010 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
GenMark Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.09B $0.03B 3.15
2019-12-31 $0.08B $0.02B 3.43
2019-09-30 $0.06B $0.02B 2.69
2019-06-30 $0.06B $0.02B 3.39
2019-03-31 $0.07B $0.02B 3.93
2018-12-31 $0.07B $0.02B 3.37
2018-09-30 $0.07B $0.02B 3.75
2018-06-30 $0.07B $0.04B 2.04
2018-03-31 $0.09B $0.03B 2.79
2017-12-31 $0.10B $0.03B 3.45
2017-09-30 $0.10B $0.04B 2.97
2017-06-30 $0.12B $0.03B 3.60
2017-03-31 $0.04B $0.02B 2.00
2016-12-31 $0.06B $0.03B 2.21
2016-09-30 $0.07B $0.02B 3.26
2016-06-30 $0.05B $0.02B 2.95
2016-03-31 $0.05B $0.01B 4.03
2015-12-31 $0.06B $0.01B 5.28
2015-09-30 $0.06B $0.01B 5.41
2015-06-30 $0.07B $0.01B 7.44
2015-03-31 $0.08B $0.01B 8.15
2014-12-31 $0.08B $0.01B 6.35
2014-09-30 $0.09B $0.01B 7.33
2014-06-30 $0.09B $0.01B 8.02
2014-03-31 $0.10B $0.01B 10.15
2013-12-31 $0.11B $0.01B 10.85
2013-09-30 $0.12B $0.01B 14.02
2013-06-30 $0.05B $0.01B 5.86
2013-03-31 $0.05B $0.01B 6.62
2012-12-31 $0.06B $0.01B 6.32
2012-09-30 $0.06B $0.01B 7.83
2012-06-30 $0.07B $0.01B 10.04
2012-03-31 $0.03B $0.01B 5.03
2011-12-31 $0.03B $0.01B 5.31
2011-09-30 $0.04B $0.01B 6.09
2011-06-30 $0.05B $0.01B 6.91
2011-03-31 $0.02B $0.00B 4.31
2010-12-31 $0.02B $0.00B 6.82
2010-09-30 $0.03B $0.00B 6.87
2010-06-30 $0.03B $0.00B 8.61
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.954B $0.088B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $150.978B 30.66
Intuitive Surgical (ISRG) United States $68.179B 50.36
Edwards Lifesciences (EW) United States $43.085B 36.21
DexCom (DXCM) United States $39.079B 182.40
IDEXX Laboratories (IDXX) United States $28.832B 67.89
ALCON INC (ALC) Switzerland $28.721B 32.15
Fresenius Medical Care AG KGaA (FMS) Germany $26.348B 17.95
Olympus (OCPNY) Japan $26.270B 53.43
Teleflex (TFX) United States $17.092B 31.66
Sysmex ADR (SSMXY) Japan $15.611B 44.00
Hologic (HOLX) United States $14.940B 23.52
SONOVA HOLDING (SONVY) Switzerland $13.957B 0.00
STERIS (STE) Ireland $13.053B 27.24
Masimo (MASI) United States $12.695B 69.00
ABIOMED (ABMD) United States $11.991B 64.30
Varian Medical Systems (VAR) United States $11.131B 27.00
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.708B 258.46
Tandem Diabetes Care (TNDM) United States $6.112B 0.00
Globus Medical (GMED) United States $4.448B 28.15
Integra LifeSciences Holdings (IART) United States $4.089B 18.75
Nevro (NVRO) United States $3.997B 0.00
Wright Medical Group (WMGI) Netherlands $3.873B 601.00
Elekta AB (EKTAY) Sweden $3.675B 28.29
Nihon Kohden (NHNKY) Japan $2.694B 0.00
LivaNova (LIVN) United Kingdom $2.522B 19.01
OPKO Health (OPK) United States $2.519B 0.00
Integer Holdings (ITGR) United States $2.349B 14.51
Cantel Medical (CMD) United States $1.900B 21.99
Glaukos (GKOS) United States $1.721B 0.00
ShockWave Medical (SWAV) United States $1.526B 0.00
Luminex (LMNX) United States $1.517B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.453B 28.18
Veracyte (VCYT) United States $1.431B 0.00
Silk Road Medical (SILK) United States $1.340B 0.00
Mesa Laboratories (MLAB) United States $0.978B 51.71
Accelerate Diagnostics (AXDX) United States $0.886B 0.00
Inogen (INGN) United States $0.823B 49.09
OrthoPediatrics (KIDS) United States $0.780B 0.00
Tactile Systems Technology (TCMD) United States $0.769B 97.54
CryoLife (CRY) United States $0.737B 102.84
Natus Medical (NTUS) United States $0.734B 18.10
Quotient (QTNT) Switzerland $0.633B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.614B 24.81
Pacific Biosciences Of California (PACB) United States $0.606B 0.00
Intersect ENT (XENT) United States $0.460B 0.00
AxoGen (AXGN) United States $0.454B 0.00
Si-Bone (SIBN) United States $0.452B 0.00
Repro-Med Systems (KRMD) United States $0.393B 301.33
AngioDynamics (ANGO) United States $0.391B 26.00
TransMedics (TMDX) United States $0.372B 0.00
Vermillion (AWH) United States $0.357B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 0.00
ViewRay (VRAY) United States $0.332B 0.00
Fluidigm (FLDM) United States $0.309B 0.00
Stereotaxis (STXS) United States $0.304B 0.00
Alphatec Holdings (ATEC) United States $0.300B 0.00
Semler Scientific (SMLR) United States $0.297B 32.83
IRadimed (IRMD) United States $0.292B 31.43
SeaSpine Holdings (SPNE) United States $0.274B 0.00
RTI Surgical (RTIX) United States $0.212B 0.00
Sientra (SIEN) United States $0.198B 0.00
Accuray (ARAY) United States $0.197B 0.00
CRH Medical (CRHM) Canada $0.165B 115.00
T2 Biosystems (TTOO) United States $0.160B 0.00
Electromed (ELMD) United States $0.132B 33.85
Restoration Robotics (VERO) Canada $0.110B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.090B 0.00
EDAP TMS S.A (EDAP) France $0.072B 35.29
ConforMIS (CFMS) United States $0.059B 0.00
MRI Interventions (CLPT) United States $0.055B 0.00
Bioanalytical Systems (BASI) United States $0.055B 0.00
Ekso Bionics Holdings (EKSO) United States $0.054B 0.00
Sensus Healthcare (SRTS) United States $0.049B 0.00
Allied Healthcare Products (AHPI) United States $0.044B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.042B 0.00
Apollo Endosurgery (APEN) United States $0.036B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
Delcath Systems (DCTH) United States $0.026B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.022B 0.00
Second Sight Medical Products (EYES) United States $0.022B 0.00
Sunshine Heart Inc (CHFS) United States $0.021B 0.00
Helius Medical Technologies (HSDT) United States $0.020B 0.00
TransEnterix (TRXC) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Dynatronics (DYNT) United States $0.014B 0.00
Xtant Medical Holdings (XTNT) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
American Shared Hospital Services (AMS) United States $0.012B 43.60
Lianluo Smart (LLIT) China $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Nanovibronix (NAOV) United States $0.009B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Ra Medical Systems (RMED) United States $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.002B 0.00